The US Food and Drug Administration (FDA) has approved the B-cell depleting agent inebilizumab-cdon (Uplizna, Amgen) for the treatment of immunoglobulin G4-related disease (IgG4-RD). This is the first and only treatment approved for this rare autoimmune disease in the United States. An estimated 200,000 people in the United States are living with IgG4-RD...
https://launchlinks.com/jacemembers
.png)
7200 Powers Ave. #151 Jacksonville, Florida 32217
19047291091
jtparish02@outlook.com
Copyright © 2023 jacenews24. All Rights Reserved
